ABVC BioPharma, Inc. (NASDAQ:ABVC – Get Free Report) was the target of a large drop in short interest in January. As of January 15th, there was short interest totalling 360,300 shares, a drop of 42.6% from the December 31st total of 628,000 shares. Based on an average trading volume of 266,100 shares, the short-interest ratio is currently 1.4 days. Currently, 3.2% of the shares of the stock are short sold.
ABVC BioPharma Price Performance
Shares of NASDAQ:ABVC opened at $0.54 on Wednesday. The company has a market cap of $6.94 million, a price-to-earnings ratio of -0.62 and a beta of 0.70. The firm has a 50 day simple moving average of $0.54 and a 200 day simple moving average of $0.62. ABVC BioPharma has a one year low of $0.41 and a one year high of $1.73.
ABVC BioPharma Company Profile
Read More
- Five stocks we like better than ABVC BioPharma
- The 3 Best Fintech Stocks to Buy Now
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Top Biotech Stocks: Exploring Innovation Opportunities
- What Does the Future Hold for Eli Lilly?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for ABVC BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ABVC BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.